CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 119 filers reported holding CLOVIS ONCOLOGY INC in Q2 2022. The put-call ratio across all filers is 0.93 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $33,000 | -25.0% | 16,243 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $44,000 | -38.9% | 16,243 | 0.0% | 0.00% | -66.7% |
| Q3 2021 | $72,000 | -23.4% | 16,243 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $94,000 | -17.5% | 16,243 | 0.0% | 0.00% | -25.0% |
| Q1 2021 | $114,000 | +32.6% | 16,243 | -9.3% | 0.00% | +33.3% |
| Q4 2020 | $86,000 | – | 17,915 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |